RESULTS AND DISCUSSION {#S1}
======================

Neandertals ([Figure 1A](#F1){ref-type="fig"}) and modern humans ([Figure 1B](#F1){ref-type="fig"}) have similar endocranial volumes but distinct endocranial shapes. Modern humans have a globular-shaped braincase, with a round and expanded posterior cranial fossa housing the cerebellum, and more bulging parietal bones \[[@R2]--[@R4]\]. Contrasting the average endocranial shapes of modern humans and Neandertals, Kochiyama et al. \[[@R5]\] proposed that the biggest differences between these groups are found in the cerebellum. Comparative analyses suggest rapid evolutionary changes of this brain structure in great apes and humans \[[@R8], [@R9]\]. Our analysis of endocranial shape based on data from \[[@R4]\] demonstrates that other regions beyond the cerebellum are relatively larger in modern humans than in Neandertals, including parts of the prefrontal cortex and the occipital and temporal lobes ([Figures 1C](#F1){ref-type="fig"} and[1D](#F1){ref-type="fig"}). In contrast, parietal bulging \[[@R2]--[@R4]\] is not linked to an increased surface area, suggesting that the parietal lobe is ''displaced'' by reorganization of other---presumably subcortical---parts of the brain.

The evolutionary history of our species can currently be traced back to fossils from Jebel Irhoud (Morocco) dated to about 300,000 years ago \[[@R4], [@R10], [@R11]\]. While their faces and teeth look modern, their elongated braincases appear more like older human species and Neandertals \[[@R4], [@R10]\]. Together with crania from South Africa and Ethiopia, these fossils document an early evolutionary phase of *Homo sapiens* on the African continent \[[@R10], [@R11]\]. The globular endocranial shape emerged gradually in the *Homo sapiens* lineage, evolving independently of brain size: reorganization of cerebellar and lateral parietotemporal areas was followed by continued gradual changes in the organization of cerebellar and occipital areas \[[@R4]\]. From the perspective of ontogeny, braincase shape depends on a complex interplay between cranial bone growth, facial size, and the tempo and mode of neurodevelopment \[[@R1], [@R4], [@R12]--[@R14]\]. In present-day humans, globularity emerges during perinatal development \[[@R12], [@R13]\] in a period when the rapidly expanding brain is the main driver of braincase shape. It has therefore been proposed that endocranial globularity reflects evolutionary changes in early brain development \[[@R4], [@R12]\]. However, endocranial imprints only capture outer brain shape and cannot provide direct information about underlying features of neural reorganization.

Study Design and Hypothesis {#S2}
---------------------------

In this study, we combine paleoanthropological data from Neandertal fossils with neuroimaging and genomic data from thousands of present-day humans, as well as gene expression data, to interrogate the molecular basis of endocranial globularity. As overall endocranial shape is a complex trait, we expect that it is influenced by many genetic loci, each with only a small effect. We therefore use both phenotypic and genetic differences between modern humans and Neandertals as filters to constrain our search space. Analyses of the genomes of Neandertals and modern humans show that they encountered each other outside Africa and interbred \[[@R6], [@R15], [@R16]\]. Introgressed fragments of Neandertal DNA can be reliably identified in modern humans and are estimated to account for 1%--2% of the genomes of non-African individuals, such that collectively \~40% of the Neandertal genome is represented in people living today \[[@R17]--[@R19]\]. Here, we quantify the endocranial shape differences between Neandertals and modern humans and study how Neandertal introgressed fragments affect this phenotype.

Metric for Endocranial Globularity {#S3}
----------------------------------

Using computed tomographic (CT) scans of fossil and extant skulls, we generated virtual imprints of the interior braincase (endocasts) and quantified endocranial shape differences between modern humans from Europe (n = 19) and Neandertals (n = 7) based on a dense mesh of semilandmarks ([Figures 1C and 1D](#F1){ref-type="fig"}). We placed the same mesh on the endocranial surface segmented manually from the MNI-152 template---an average of 152 registered structural MRI scans of living humans ([Figures 1E and 1F](#F1){ref-type="fig"}). A principal component analysis of endocranial shape shows that there is no overlap between the more globular endocrania of modern humans and the more elongated endocrania of Neandertals ([Figure 2A](#F2){ref-type="fig"}). We therefore used these distinctive group differences to develop a summary metric for endocranial globularity. This ''globularity score'' quantifies overall endocranial shape by projecting the endocranial measurements of each individual onto the vector between the average shape of Neandertals and that of present-day humans ([Figure 2B](#F2){ref-type="fig"}). By applying this morphometric approach to structural MRI scans of thousands of healthy human adults (n = 6,575) from the general population (predominantly of European origin), we obtained an evolutionarily derived quantitative index of globularity, which we showed with repeat scans to be robust and reliable. We replicated the findings shown in [Figure 2](#F2){ref-type="fig"} in a more diverse endocranial dataset, building on data from \[[@R4]\] ([Figure S1](#SD1){ref-type="supplementary-material"}). As the sample composition differs from the one shown in [Figure 2](#F2){ref-type="fig"}, the values of the derived globularity scores also differ---the overall pattern, however, remains highly consistent. Endocranial shapes extracted from CT and MRI scans largely overlap in both analyses ([Figures 2](#F2){ref-type="fig"}, [S1B](#SD1){ref-type="supplementary-material"}, and [S1C](#SD1){ref-type="supplementary-material"}).

Voxel-Based Morphometry {#S4}
-----------------------

We explored potential underlying structural contributions to interindividual variation in the globularity phenotype in healthy present-day humans using voxel-based morphometry (VBM) of MRI scans in two large European cohorts from Germany (SHIP and SHIP-Trend, total n = 2,929). These analyses revealed multiple significant (p(peak,FWE) % 0.025) clusters where globularity was positively or negatively associated with interindividual variability in gray matter (GM). In both hemispheres, greater values of globularity were associated with higher GM volumes in temporal regions, vermis and adjacent parts of the cerebellum, and in subcortical structures including the hippocampus, thalamus, amygdala, caudate, and putamen ([Figure S2](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}). A significant inverse relationship of globularity and GM ([Table S2](#SD1){ref-type="supplementary-material"}) was detected in large parts of the frontal, temporal, and occipital gyri; parts of the cerebellum; and several subcortical regions (thalamus, putamen, hippocampus).

Effect of Introgressed Neandertal Alleles {#S5}
-----------------------------------------

To investigate molecular correlates of the fossil-based globularity score, we used genotype data from European individuals to identify introgressed Neandertal alleles \[[@R18], [@R20]\] and studied their association with variability in this phenotype. We analyzed five datasets comprising 4,468 individuals with European ancestry for whom both MRI and genotype data were available: three batches of the Dutch BIG cohort (total n = 2,433) and the genotyped subsets of the German SHIP (n = 1,139) and SHIP-Trend (n = 896) cohorts, mentioned above. We analyzed each of 50,057 archaic SNPs with a minor allele frequency (MAF) of at least 0.01, testing the hypothesis that Neandertal-introgressed fragments would promote elongation of endocranial shape in modern humans (controlling for age, sex, ancestry, and scanning parameters). These SNPs cover 42% of the known, high-confidence Neandertal haplotypes \[[@R20]\] ([Figures 3A and 3B](#F3){ref-type="fig"}). Although the cohorts were all European, we used multidimensional scaling (MDS) to exclude outlier individuals and, for extra rigor, accounted for residual effects of population stratification using principal components (PCs). Prior to association analysis, we designated significance thresholds that appropriately account for the extent of multiple testing, based on the linkage disequilibrium structure within the set of Neandertal alleles being tested (6,778 independent tests, estimated using the Genetic Type 1 error calculator \[[@R21]\]). Thus, our multiple-testing corrected thresholds were p \< 7.38 × 10^−6^ for significant association and p \< 1.48 × 10^−4^ for suggestive association, following standard guidelines of the field.

Five SNPs within a \~200 kilobase (kb) archaic haplotype on chromosome 1 spanning 1:19244479--19453365 passed the significance threshold (top SNP 1:19365951, p = 3.26 × 10^−6^). A second Neandertal haplotype on chromosome 18 (500 kb, 18:60279290--60776578) contains six SNPs that passed the suggestive significance threshold (top SNP 18:60691999, p = 5.66 × 10^−5^). A single SNP, representing a 170 kb haplotype on chromosome 14 (14:50535915, p = 9.29 × 10^−5^), also passed suggestive significance. All haplotypes showed consistent directions of effect across all five datasets from the three cohorts, with the Neandertal-like haplotypes showing association with more oblong endocranial shape ([Figure 3C](#F3){ref-type="fig"}) and with the top SNPs each showing an additive effect (i.e., heterozygous carriers were intermediate in score between homozygous groups; [Figure 3D](#F3){ref-type="fig"}). We checked the top SNP at each locus to further discount residual effects of population stratification by increasing the number of PCs from 2 to 15. In this conservative follow-up analysis, there was a slight attenuation of signals: the chromosome-1 association remained significant (p = 6.94 × 10^−6^), and the chromosome-18 association remained suggestive (p = 9.54 × 10^−5^), but the isolated chromosome-14 SNP dropped below the threshold (p = 0.00019). The MAFs for the top SNPs were low in all three European cohorts, and very few individuals were homozygous for the Neandertal alleles (1:19365951, MAF = 0.0436, 8 homozygotes; 18:60691999, MAF = 0.052, 6 homozygotes; 14:50535915, MAF = 0.0204, 1 homozygote; [Figure 3D](#F3){ref-type="fig"}). As expected for a genetically complex neuroanatomical phenotype \[[@R22]\], effect sizes of individual SNPs were small ([Figure 3C](#F3){ref-type="fig"}) but detectable here due to inclusion of cohorts comprising thousands of individuals.

A recent study explored Neandertal DNA variants and brain shape in a substantially smaller sample of present-day humans \[[@R23]\]. The authors looked for associations between features of brain shape and a composite score reflecting the overall percentage of Neandertal DNA that a person carries. However, because individual introgressed fragments are rare, two people can have the same total amount of Neandertal-derived DNA, and thus an identical summary score, but share few (if any) Neandertal variants. Thus, it is difficult to draw biologically informative conclusions from overall genomic percentages, limiting the interpretation of the prior study. In their analysis of only 146 people, the authors highlighted Neandertal SNPs in the *GPR26* gene as being of particular interest \[[@R23]\]; we assessed these markers in our sample of 4,468 individuals but saw no association with variability in endocranial globularity (all p \> 0.05).

Gene Expression {#S6}
---------------

The associated SNPs lie outside protein-coding regions, but could potentially affect expression of nearby genes, in the brain and other tissues. We tested this hypothesis for the Neandertal haplotypes tagged by the two top SNPs on chromosome 1 and 18 using the GTEx database of expression quantitative trait loci (eQTL) data from over 400 donors \[[@R24]\]. To increase our power to detect associations with Neandertal introgressed alleles, which tend to be at lower frequency in present-day genomes, we used a set of Neandertal eQTLs that were previously defined, based on the top 5% of genes in each GTEx tissue showing association between gene expression and the presence of a nearby introgressed archaic haplotype \[[@R25]\]. The Neandertal variants that were associated with lower globularity scores showed modest but consistent effects on the expression in brain tissues of nearby genes that regulate multiple aspects of brain growth. Among the top 5% eQTL associations, we found that the chromosome-1 SNP, 1:19365951 (rs28445963), which had the strongest association with endocranial shape in our study, showed significant eQTLs in multiple tissues, including downregulation of *UBR4* in the putamen (part of the basal ganglia) in carriers of the Neandertal allele ([Figures 4A and 4B](#F4){ref-type="fig"}; Spearman correlation p = 0.031). The Neandertal allele of the most highly associated chromosome-18 SNP, 18:60691999 (rs72931809), was associated with upregulation of *PHLPP1* in the cerebellum ([Figures 4C--4D](#F4){ref-type="fig"}, Spearman correlation p = 0.024). Additional eQTL associations of these SNPs in other tissues are shown in [Figures S3](#SD1){ref-type="supplementary-material"} and [S4](#SD1){ref-type="supplementary-material"}.

*UBR4* encodes a ubiquitin ligase that regulates neurogenesis in the developing neocortex and promotes neuronal migration, among other roles \[[@R26]\]. Loss of the mouse ortholog (called *p600*) in the developing brain impairs neurogenesis, resulting in microcephaly \[[@R27]\]. In humans, *UBR4* is intolerant to loss-of-function mutations (pLI score = 1.0), suggesting that even small expression changes may have functional consequences \[[@R28]\].

*PHLPP1* encodes a negative regulator of the PI3K/Akt growth-factor signaling pathway that drives myelination. Overexpression of Akt in transgenic mice leads to hypermyelination compared to wild-type controls \[[@R29]\]. With a high pLI score (0.92), *PHLPP1* is a tumor suppressor in humans and mice \[[@R30], [@R31]\]. The PI3K/ AKT/mTOR signaling pathway broadly promotes brain growth and development of the myelin sheath \[[@R32]--[@R35]\]. In carriers of the Neandertal allele, *PHLPP1* expression is slightly higher in the cerebellum, which would be predicted to have dampening effects on Akt-driven cerebellar myelination, consistent with the less globular endocranial shape associated with this allele in our study. However, comparative studies indicate that the increased endocranial globularity of present-day humans as compared to Neandertals is not merely the result of absolute cerebellar enlargement \[[@R4], [@R5]\], suggesting that endocranial shape variation involves complex shifts in relative, rather than absolute, volumes of different brain structures. This viewpoint is supported also by our VBM analyses of interindividual differences in globularity, which found that such variation involves both positive and negative GM changes, distributed across various brain regions. In one of the cohorts that we studied here, more globular modern human endocrania have slightly smaller absolute cerebellar volumes ([Table S3](#SD1){ref-type="supplementary-material"}), but this subtle effect was not observed in the other cohorts. The VBM analyses suggest that, at least within present-day Europeans, higher endocranial globularity is associated with increased GM in some parts of the cerebellum but also with decreased GM in others ([Figure S2](#SD1){ref-type="supplementary-material"}; [Tables S1](#SD1){ref-type="supplementary-material"} and [S2](#SD1){ref-type="supplementary-material"}).

Conclusions {#S7}
-----------

We have integrated evidence from paleoanthropology, comparative genomics, neuroimaging, and gene expression to begin identifying genes associated with variation in endocranial globularity, a defining feature of modern humans. The directions of effect were consistent in five separate batches of data from three independent cohorts and consistent with our hypothesis that Neandertal alleles would push the endocranium toward a more elongated shape. The associated variants were connected to genes involved in neurogenesis and myelination pathways in putamen and cerebellum, respectively. The eQTL data suggest that Neandertal alleles near *UBR4* and *PHLPP1* are linked to lower levels of neural proliferation. We speculate that this may contribute to altered neuroanatomical morphology of some subcortical structures and the cerebellum and thereby to lower overall globularity. The Neandertal haplotypes may thus be associated with developmental gene expression patterns that influence endocranial globularity through effects on neurogenesis and myelination during brain development. Functional impacts of Neandertal alleles on neural properties and brain development can in future be empirically tested \[[@R36]\], for example by using gene-editing techniques to insert changes into human induced pluripotent stem cells, which can be differentiated into distinct types of neurons or organoids.

Globularity is a multifactorial trait, involving combined influences of many different loci, and the effects of individual SNPs on overall endocranial shape are small. It is likely that future genome-wide studies in sufficiently large high-powered samples will reveal additional relevant genes and associated pathways. The potential links between evolutionary changes in endocranial globularity and mechanisms affecting the basal ganglia and cerebellum are nevertheless intriguing, because both brain structures receive direct input from the motor cortex and are involved in the preparation, learning, and sensorimotor coordination of movements. Expanded cerebellar interconnections with prefrontal, premotor, and superior-posterior parietal cortices, which also project densely to the putamen, may be particularly relevant to cognitive abilities of modern humans \[[@R9], [@R37], [@R38]\]. In addition to their involvement in sensorimotor coordination, the basal ganglia also contribute to diverse cognitive functions in memory, attention, planning, skill learning \[[@R39]\], and potentially to speech and language evolution \[[@R40], [@R41]\].

STAR\*METHODS {#S8}
=============

KEY RESOURCES TABLE {#S9}
-------------------

  REAGENT or RESOURCE                                                                        SOURCE                                                                                                       IDENTIFIER
  ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------ -----------------
  Critical Commercial Assays                                                                                                                                                                              
  1.5 Tesla Siemens Sonata and Avanto scanners, 3 Tesla Siemens Trio and Trio TIM scanners   Siemens Medical Systems, Erlangen, Germany                                                                   N/A
  3 Tesla GE MR750 scanner                                                                   General Electric, USA                                                                                        N/A
  Affymetrix 6.0 genotyping array                                                            Affymetrix, USA                                                                                              N/A
  PsychChip genotyping array                                                                 Psychiatric Genomics Consortium, USA                                                                         RRID:SCR_004495
  OmniExpress genotyping array                                                               Illumina, USA                                                                                                N/A
  Omni 2.5 genotyping array                                                                  Illumina, USA                                                                                                N/A
                                                                                                                                                                                                          
  Deposited Data                                                                                                                                                                                          
  Introgressed Neandertal SNPs                                                               \[[@R18], [@R20]\]                                                                                           N/A
  GTEx eQTL data                                                                             [gtexportal.org](http://gtexportal.org)                                                                      RRID:SCR_013042
  BrainSpan Atlas                                                                            <http://www.brainspan.org/static/download.html>                                                              RRID:SCR_008083
                                                                                                                                                                                                          
  Software and Algorithms                                                                                                                                                                                 
  Globularity measurement script (Mathematica)                                               This Study                                                                                                   N/A
  FreeSurfer (v5.3)                                                                          <http://surfer.nmr.mgh.harvard.edu/>                                                                         RRID:SCR_001847
  FSL FIRST (v5.0, v5.0.9), FLIRT (v6.0)                                                     <https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/>                                                                    RRID:SCR_002823
  Avizo                                                                                      Thermo Scientific                                                                                            RRID:SCR_014431
  Mathematica                                                                                Wolfram                                                                                                      RRID:SCR_014448
  SPM12                                                                                      Wellcome Trust Centre for Neuroimaging, University College London                                            RRID:SCR_007037
  CAT12 toolbox                                                                              Christian Gaser, University of Jena, Germany, <http://www.neuro.uni-jena.de>                                 N/A
  xjview toolbox                                                                             <http://www.alivelearn.net/xjview>                                                                           RRID:SCR_008642
  PLINK                                                                                      <https://www.cog-genomics.org/plink2/>                                                                       RRID:SCR_001757
  minimac (release 2012--05-29)                                                              <https://genome.sph.umich.edu/wiki/Minimac>                                                                  RRID:SCR_009292
  mach2qtl                                                                                   <https://www.unc.edu/~yunmli/software.html>                                                                  RRID:SCR_009621
  IMPUTE (v2.2.2)                                                                            <http://mathgen.stats.ox.ac.uk/impute/impute.html>                                                           RRID:SCR_009245
  QUICKTEST (v0.99b)                                                                         <https://wp.unil.ch/sgg/quicktest/>                                                                          N/A
  easyQC                                                                                     <https://www.uni-regensburg.de/medizin/epidemiologie-praeventivmedizin/genetische-epidemiologie/software/>   N/A
  METAL                                                                                      <https://genome.sph.umich.edu/wiki/METAL_Documentation>                                                      RRID:SCR_002013
  Genomic Type 1 Error Calculator                                                            <http://grass.cgs.hku.hk/gec/>                                                                               N/A
  DESeq2                                                                                     <https://bioconductor.org/packages/release/bioc/html/DESeq2.html>                                            RRID:SCR_015687

CONTACT FOR REAGENT AND RESOURCE SHARING {#S10}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Simon E. Fisher (<simon.fisher@mpi.nl>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S11}
--------------------------------------

### Participants {#S12}

The Nijmegen ''Brain Imaging Genetics'' (BIG) cohort is a Dutch population-based sample of healthy, unrelated volunteers. Established in 2007, BIG is part of Cognomics, a joint initiative by the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Centre, and the Max Planck Institute for Psycholinguistics. MRI and genetic data were collected from individuals at the Donders Center for Cognitive Neuroscience, in Nijmegen, the Netherlands. The BIG dataset has been described in several previous studies \[[@R42], [@R43]\]. The MRI data in the present study come from 2,913 participants (53% female), with an average age of 27 years (range 17--82). The genetic data presented come from a subset of 2,433 individuals (53% female), with an average age of 25 years (range 18--82). All participants gave written informed consent for analysis of both their DNA and MRI scans, and the regional ethics committee approved the study.

The ''Study of Health in Pomerania'' (SHIP), established in 1997, is a prospective cohort study, part of the Community Medicine Research net of the University of Greifswald. SHIP is a population-based project in West Pomerania, a region in the northeast of Germany, that consists of two independent prospectively collected cohorts (SHIP and SHIP-Trend) assessing the prevalence and incidence of common population-based diseases and their risk factors. The study design has been previously described in detail \[[@R44]\]. For SHIP, baseline examinations were carried out from 1997 until 2001, and the sample finally comprised 4,308 participants. Baseline examinations for SHIP-Trend were carried out between 2008 and 2012, finally comprising 4,420 participants. We conducted a voxel-based morphometry (VBM) analysis \[[@R45]\] on individuals from SHIP and SHIP-TREND. Complete datasets (including MRI, globularity score, and covariates for adjustments) were available for 3,309 subjects. After exclusion of medical conditions (e.g., a history of cerebral tumor, stroke, Parkinson's diseases, multiple sclerosis, epilepsy, hydrocephalus, enlarged ventricles, pathological lesions) or technical reasons (e.g., severe movement artifacts or inhomogeneity of the magnetic field) 2,952 subjects were available. We finally performed the homogeneity check and excluded 23 extreme outliers. Our final sample for the VBM analysis consisted of 2,929 individuals (53% female). So as to study the effect of Neandertal alleles on globularity we used samples from the second five-year follow-up of SHIP (SHIP-2, n = 1,139) and the baseline of SHIP-Trend (n = 896) for which both MRI and genotype data were available. The samples had an average age of 56 (range 30--90) years for SHIP-2, and 50 (range 22--81) years for SHIP-Trend. The cohorts included 51% and 56% females for SHIP-2 and SHIP-Trend, respectively. The medical ethics committee of the University of Greifswald approved the study protocol, and oral and written informed consents were obtained from each of the study participants.

The ''Function Biomedical Informatics Research Network'' (FBIRN) Phase 3 cohort included 186 individuals with schizophrenia (average age 38 years, 22% female) and 176 healthy volunteers (average age 37.5 years, 28% female) with an age range of 18--62 years. Written informed consent, including permission to share de-identified data between the centers, approved by the University of California Irvine, Los Angeles, and San Francisco, Duke University, University of North Carolina, New Mexico, Iowa, and Minnesota Institutional Review Boards, was obtained from all study participants. The study methods have been previously described in detail \[[@R46]\]. Data from FBIRN was included in the initial description of brain globularity (see Methods - Structural MRI), however, the cohort was not included in the genetic association analyses (see Methods - Genotyping, Statistical analyses).

METHOD DETAILS {#S13}
--------------

### Structural MRI {#S14}

In the BIG cohort, MRI data were obtained using either a 1.5 Tesla Siemens Sonata or Avanto scanner, or a 3 Tesla Siemens Trio or Trio TIM scanner (Siemens Medical Systems, Erlangen, Germany). Image processing was completed using FreeSurfer version 5.3 and FSL FIRST version 5.0 with FLIRT version 6.0, as described previously \[[@R42]\].

In the SHIP cohorts, participants were scanned using a 1.5 Tesla Siemens Avanto scanner, and image processing was completed using FreeSurfer 5.3 and FSL FIRST version 5.0.9 (with FLIRT version 6.0).

The FBIRN Phase 3 cohort was scanned at 7 sites using six 3 Tesla Siemens Trio TIM (Siemens, Erlangen, Germany) and one 3 Tesla GE MR750 scanner (General Electric, USA). Image processing was completed using FreeSurfer 5.3 and FSL FIRST version 5.0.9 (with FLIRT version 6.0). In all cohorts, visual inspection was used to resolve potential outliers.

### Computed tomography {#S15}

Original fossil human crania (n = 7) and a European sample of recent modern human adults (n = 19) were scanned using computed tomography (CT). The sample shown in [Figure 2](#F2){ref-type="fig"} comprises the *Homo neanderthalensis* specimens Gibraltar 1 (labeled as Gi), Guattari (Gu), La Chapelle-aux-Saints (LC), La Ferrassie 1 (LF), Le Moustier 1 (LM1), and the *Homo heidelbergensis* specimens Kabwe (Ka) and Petralona (Pe).

For all CT specimens, virtual endocasts of the braincase were created using segmentation in Avizo (Thermo Scientific) following \[[@R4]\]. Any missing data in fossil specimens were reconstructed using established protocols \[[@R47]--[@R49]\].

### Globularity score computation for MRI scans {#S16}

To quantify the endocranial shape differences between modern humans and Neandertals, we combined the methods of geometric morphometrics \[[@R48]\] using scripts in Mathematica (Wolfram Inc.) with standard neuroimaging data processing protocols (FSL 5.0 and FreeSurfer 5.3). On each virtual endocast, we first distributed a dense mesh of semilandmarks \[[@R4], [@R47]--[@R49]\]. The same mesh of semilandmarks was distributed on an endocast segmented manually from the MNI 152 brain template (MNI 152 T1 2 mm). Semilandmarks are a geometric morphometric technique for quantifying relatively smooth curves and surfaces based on the same number 3D coordinates on each individual \[[@R4]\]. One starts by distributing the same number of 3D coordinates in approximately corresponding locations on each individual. Subsequently these semilandmarks are allowed to slide along the surface so as to remove the influence of the arbitrary initial point spacing. Our iterative semilandmark algorithm allows the surface semilandmarks to slide along tangent planes until the Procrustes distance between each individual and a template shape is minimal (this template shape can be sample average shape, or a single individual as detailed below), and projects the semilandmarks back onto the surface. These iterative sliding steps establish geometric homology among the semilandmarks within a sample \[[@R48], [@R49]\].

Next, we registered the FreeSurfer segmentation of each MRI scan to the MNI 152 template: we used ''*mri_label2vol''* to register wmparc.mgz to the respective individual's native anatomical space (rawavg.mgz), and then the command ''*flirt''* to create a transformation matrix between this image and the MNI 152 template. Subsequently, we used ''*convert_xfm -omat''* to create an inverse of this transformation matrix.

In Mathematica, we then applied the inverse of each transformation matrix to the 3D coordinates of the dense mesh of semilandmarks on the MNI 152 template, thereby bringing the semilandmarks into the native anatomical space of each individual. Next, we allowed the semilandmarks on all specimens (i.e., CT scans and MRI scans) to slide so as to minimize the Procrustes distance between each individual and the MNI 152 template (following ref. \[[@R49]\]). This sliding step establishes geometric homology of the semilandmarks \[[@R4], [@R47]--[@R49]\].

We then used Procrustes superimposition on the slid semilandmarks to standardize location and orientation and to scale them to the same centroid size \[[@R48]\]. These Procrustes shape variables were analyzed using principal component analysis ([Figure 2A](#F2){ref-type="fig"}). To quantify globularity, we computed the difference between the Procrustes mean shape of the Neandertal endocrania and the average shape of all modern European endocrania extracted from CT scans. We then projected the Procrustes shape coordinates of all endocrania (i.e., CT and MRI data) onto this multivariate group-difference vector ([Figure 2B](#F2){ref-type="fig"}). This final step yields a ''globularity score'' for each individual, a reliable continuous trait with a normal distribution, which we used to quantify the phenotype. A subsample (n = 399) of repeated MRI scans (from the BIG cohort) of the same individual on different occasions shows that this ''globularity score'' has a high test-retest repeatability, with a correlation of 0.97 after correcting for scanning covariates.

### Complementary shape analysis and globularity score {#S17}

We replicated the findings shown in [Figure 2](#F2){ref-type="fig"} in a more diverse endocranial dataset ([Figure S1](#SD1){ref-type="supplementary-material"}). This complementary shape analysis is based on endocranial data published in \[[@R4]\], with two additional Neandertal specimens (Saccopastore 1 and Le Moustier 1). This dataset comprises coordinate measurements on computer-generated endocasts of a geographically diverse sample of recent modern human adults (n = 89; the European specimens overlap with the crania used in the main text [Figure 2](#F2){ref-type="fig"}) and fossil humans (n = 20): 8 fossil *Homo erectus* specimens --- KNM-ER 3733 (labeled as ER3733 in [Figure S1](#SD1){ref-type="supplementary-material"}), KNM-ER 3883 (ER3883), KNM-WT 15000 (WT15k), OH 9, Ngandong 14 (Ng14), Ngawi (Nga), Sambungmacan 3 (Sam3), and Sangiran 2 (Sa2), and the *Homo heidelbergensis* specimens Kabwe (Ka), and Petralona (Pe). The Neandertal sample includes Amud 1 (labeled as A1), Feldhofer 1 (Fe), Gibraltar 1 (Gi), Guattari 1 (Gu), La Chapelle-aux-Saints (LC), La Ferrassie 1 (LF), Le Moustier 1 (LM1), Saccopastore 1 (SAC1), Spy 1 (S1), and Spy 2 (S2). A manual endocranial segmentation of the MNI 152 template ([Figures 1E](#F1){ref-type="fig"} and[1F](#F1){ref-type="fig"}) was measured following the measurement and data processing protocol of \[[@R4]\]. We then used the same transformation matrices as for the computations in the main text ([Figure 2](#F2){ref-type="fig"}) to transform these landmarks and semilandmarks to the native space of each MRI scan. After a Procrustes superimposition these shape coordinate data were analyzed using between-group principal component analysis based on the group mean endocranial shapes of *Homo erectus*, *Homo neanderthalensis*, and recent *Homo sapiens* ([Figure S1B](#SD1){ref-type="supplementary-material"}). Globularity scores for this dataset were computed as described above for [Figure 2B](#F2){ref-type="fig"}. *Homo erectus*, Neandertals, and modern humans have distinct endocranial shapes ([Figure S1B](#SD1){ref-type="supplementary-material"}). Whereas the globularity scores of Neandertals and *Homo erectus* overlap completely (indicating that both groups have elongated endocranial shapes), modern humans form a distinct cluster without overlap ([Figure S1C](#SD1){ref-type="supplementary-material"}).

### Characterization of the phenotype {#S18}

Aspects of brain shape variation within modern humans have recently been linked to naturally occurring brain size variation \[[@R50]\]. Our evolutionarily-derived measure of brain globularity, however, is not related to brain size, as we found no significant correlation between globularity and intracranial volume ([Table S3](#SD1){ref-type="supplementary-material"}). Moreover, the evolutionary trajectory of globularity within *Homo sapiens* is not related to endocranial volume, and the adult endocranial volumes of *Homo sapiens* and Neandertals overlap \[[@R4]\].

We found that endocranial globularity subtly changes with age in modern adult Europeans, with older adults having slightly higher globularity scores (i.e., more rounded endocranial shapes) ([Table S3](#SD1){ref-type="supplementary-material"}). Notably, however, not a single modern human individual overlapped with Neandertals in overall endocranial shape ([Figure 1F](#F1){ref-type="fig"}, [Figure 2B](#F2){ref-type="fig"}) and thus globularity score ([Figure 1G](#F1){ref-type="fig"}, [Figure 2C](#F2){ref-type="fig"}). Longitudinal MRI data may be able to identify the factors contributing to this subtle age-effect, whether it be due to regional differences in brain volume loss or other processes.

Several studies have associated Neandertal-introgressed genetic variants with variability in phenotypes in modern humans, such as immunity, metabolism, and adaptation to environmental conditions, like temperature and sunlight, as well as neurological and behavioral phenotypes related to depression and addiction \[[@R17]--[@R20], [@R51]\]. To understand whether endocranial globularity is associated with other evolutionarily-linked traits, we tested their partial correlations in the SHIP-2 and SHIP-TREND cohorts ([Table S3](#SD1){ref-type="supplementary-material"}). Controlling for the effect of age, we saw no significant correlation between the globularity measure and any trait previously associated with Neandertal introgressed alleles.

### Voxel-based morphometry analysis {#S19}

MRI scans were processed for voxel-based analysis ([Figure S2](#SD1){ref-type="supplementary-material"}, [Tables S1](#SD1){ref-type="supplementary-material"} and [S2](#SD1){ref-type="supplementary-material"}) with SPM12 (Wellcome Trust Centre for Neuroimaging, University College London) and the CAT12 toolbox (developed by Christian Gaser, University of Jena, Germany, [www.neuro.uni-jena.de](http://www.neuro.uni-jena.de/)). The images were bias-corrected, spatially normalized by using the high-dimensional DARTEL normalization, segmented into the different tissue classes, modulated for non-linear warping and affine transformations and smoothed by a Gaussian kernel of 8 mm FWHM. The homogeneity of gray matter images was checked using the covariance structure of each image with all other images (outlier R 3 standard deviations from the mean), as implemented in the check data quality function in the CAT12 toolbox. We ran a linear regression model in every voxel of the gray matter segmentations with the globularity score as the exposure variable and adjusted for the following covariates: age (modeled continuously using restricted cubic splines), sex, ICV, and cohort (SHIP, SHIP-Trend). The statistical threshold for significant voxels was set to family wise error (FWE)-corrected peak-level p values p~peak,FWE~\<0.025 as we were testing two-sided for positive and negative associations with globularity. The labeling of the significant clusters was done within the xjview toolbox (<http://www.alivelearn.net/xjview>) on the basis of the Anatomical Automatic Labeling atlas (AAL) \[[@R52]\].

### Genotyping {#S20}

Samples from the BIG cohort were genotyped in three batches over a period of several years, using the Affymetrix 6.0, Psychiatric Genomics Consortium PsychChip, or Illumina OmniExpress arrays. The SHIP samples were genotyped using the Affymetrix 6.0 (SHIP) and Illumina Omni 2.5 (SHIP-Trend) arrays.

Sample and SNP-level quality control was performed in PLINK in accordance with the ENIGMA consortium protocol, described previously \[[@R43]\]. Briefly, sample-level quality control included missingness (SHIP: \> 8%, BIG: \> 5%) and identity-by-descent estimation (removing duplicates). Multidimensional scaling (MDS) components, as calculated in PLINK \[[@R53]\], were used to exclude any outliers resulting from population stratification.

SNPs passing initial quality control measures (SHIP: pHWE \> 0.0001 and CallRate \> 0.8; SHIP-Trend: pHWE \> 0.0001 and CallRate \> 0.9; BIG: pHWE \> 0.000001, CallRate \> 0.95) were imputed to the 1000 Genomes Project (phase 1, version 3, ALL populations) reference panel using IMPUTE v2.2.2 (SHIP) or minimac (release 2012--05-29, BIG) \[[@R54]--[@R56]\]. Variants with imputation quality scores (R^2^) higher than 0.6 were carried forward in the analyses. The reference human genome for SNP annotation was the hg19 (GRCh37) human genome assembly.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S21}
---------------------------------------

### Statistical analyses {#S22}

Partial correlations between the globularity score and other covariates were performed in R using the 'ppcor' package. Scaled globularity scores were corrected for the scanner parameters (BIG only, since the SHIP cohorts used more homogeneous acquisition), and participants' age and sex ([Table S3](#SD1){ref-type="supplementary-material"}). As noted above, based on MDS quality control checks in genotype processing, we are confident of minimal population substructure in these European cohorts. Nonetheless, for additional rigor we included the first two principal components to correct for any remaining subtle population stratification. With the model residuals as the trait, association statistics were generated with mach2qtl (BIG) or QUICKTEST version 0.99b (SHIP cohorts) using an additive model. The five sets of summary statistics were aligned using easyQC with the 1000 Genomes Project European phase 1 version 3 reference files.

We restricted our meta-analysis to the list of SNPs originating from Neandertal introgression, which was first presented \[[@R18]\] and further refined as described \[[@R20]\]. The full set included 132,296 variants that differ from the *Homo sapiens*--Neandertal common ancestor and match the Neandertal sequence. The meta-analysis was performed in METAL, using the standard error based method, a minimum minor allele frequency of 0.01, and including the genomic control option \[[@R57]\]. In follow-up tests of the three top SNPs, assessing how the number of genetic principal components in the model affected association statistics, the genomic control option was not used as the meta-analysis involved only three markers. Any SNPs missing from one or more of the cohorts were excluded, leaving 50,057 variants in the final analysis. As we tested a pre-defined, directional hypothesis that Neandertal alleles would be associated with a shift toward more archaic endocranial shapes, we calculated p values based on a one-tailed association test.

Neighboring SNPs on introgressed fragments are often in linkage disequilibrium with each other, and hence show varying degrees of non-independence in association testing. To appropriately adjust for the multiple testing of many SNPs, accounting for the existing linkage disequilibrium structure, the effective number of independent tests was calculated using the Genetic Type-1 Error Calculator (GEC), with the 1000 Genomes Project VCF as input \[[@R21]\]. Significance was assessed using the significant (7.38 3 10^---6^) and suggestive thresholds (1.48 3 10^---4^) provided by GEC.

### GTEx eQTL Analysis {#S23}

The GTEx dataset was obtained from dbGaP (accession number phs000424.v6.p1.c1, accessed on 05/23/2016). The processing of GTEx v6 data for 48 tissues, for which \> 50 individuals had available genotype data, has been described in detail elsewhere \[[@R25]\]. We retained protein-coding genes for a given tissue if there were at least two individuals in the dataset that had a read count greater than 0. We used DESeq2 to normalize all expressed genes in each tissue between individuals. For genes within 50 kilobases of a Neandertal SNP, we calculated Spearman correlations between the SNP and the normalized gene expression, if there were at least two genotypes with a minimum of two individuals each. As the top 5% of genes associated with Neandertal SNPs contained an excess of low p values, these were defined as a significant gene expression associations for each tissue, following the practice of the prior published work using this approach \[[@R25]\]: instead of simply using the eQTLs identified by GTEx consortium we re-evaluated the full dataset in order to increase power to detect associations with Neandertal introgressed alleles, which tend to be at lower frequency in present day genomes. Because of this low frequency, the power to detect associations with Neandertal alleles is more limited than for the higher frequency variants (for which the cut-offs used in the GTEx study were optimized). Additionally, the power to detect associations differs substantially between tissues as a result of the differences in sample size. We therefore used a quantile cut-off to avoid discrimination against low frequency alleles, and tissues with lower sample sizes. As a result it is possible that we identify rare Neandertal-introgressed variants that are excluded in the GTEx browser due to frequency filters. Sample sizes are listed in [Data S1](#SD2){ref-type="supplementary-material"}.

DATA AND SOFTWARE AVAILABILITY {#S24}
------------------------------

Association summary statistics are available in [Data S1](#SD2){ref-type="supplementary-material"}. The Mathematica script used to compute the globularity scores is available from the authors upon request.
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![Endocranial Shape Differences between Neandertals and Modern Humans\
(A) CT scan of the Neandertal fossil from La Chapelle-aux-Saints with a typical elongated endocranial imprint (red).\
(B) CT scan of a modern human showing the characteristic globular endocranial shape (blue). Arrows highlight the enlarged posterior cranial fossa (housing the cerebellum) as well as bulging of parietal bones in modern humans compared to Neandertals.\
(C) Average endocranial shape of adult Neandertals; each vertex of the surface corresponds to a semilandmark.\
(D) Average endocranial shape of modern humans. Areas shaded in green are relatively larger in modern humans than in Neandertals.\
(E and F) The semilandmarks used to quantify overall endocranial shape from MRI scans of living people shown on the MNI 152 template in lateral and frontal views, respectively.](nihms-1516532-f0001){#F1}

![Globularity Scores of CT and MRI Scans\
(A) Principal component analysis of endocranial shape. 99% confidence ellipses are shown for modern human CT scans from Europe (blue; n = 19), MRI scans of present-day humans (yellow; n = 6,575), and Neandertal CT scans (red; n = 7); two *Homo heidelbergensis* individuals are plotted in black.\
(B) Frequency plot of globularity scores computed for data shown in (A). This globularity score quantifies overall endocranial shape by projecting each individual onto the vector between the elongated average shape of Neandertals and the globular average shape of present-day humans. Inset shows example MRI scans associated with low (left) and high (right) globularity scores among present-day humans.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1516532-f0002){#F2}

![Endocranial Globularity in Modern Humans Is Associated with Introgressed Neandertal Haplotypes\
(A) Association statistics for introgressed Neandertal SNPs (solid line, significance, adjusted for multiple testing; dashed line, suggestive significance).\
(B) Quantile-quantile plot of association p values, showing the expected uniform distribution, with the outliers representing significant associations.\
(C) Forest plots depict the effects of the top Neandertal SNPs, for each study and genotyping batch. Boxes are proportional to weight, with whiskers representing the 95% confidence interval; diamonds represent a linear mixed-effect model incorporating all five datasets.\
(D) Covariate-corrected globularity scores by genotype. All data points are shown; boxes represent 25^th^ and 75^th^ percentiles; whiskers represent 1.5 times the interquartile range.](nihms-1516532-f0003){#F3}

![Introgressed Neandertal Fragments Associated with Globularity\
(A and C) Detailed views of the kilobase surrounding the Neandertal SNPs within the introgressed haplotypes (brown bars) on chromosomes 1 (A) and 18 (C).\
(B and D) Expression quantitative trait loci data from the GTEx resource, showing the impact of Neandertal alleles on gene expression for *UBR4* (B) and *PHLPP1* (D), as defined by \[[@R24]\].\
See also [Figures S3](#SD1){ref-type="supplementary-material"} and [S4](#SD1){ref-type="supplementary-material"}.](nihms-1516532-f0004){#F4}

###### Highlights

-   We use fossil skull data to derive an index of endocranial shape in human MRI scans

-   In 4,468 Europeans, we screen introgressed Neandertal SNPs for association with the index

-   Lead SNPs consistently associate with reduced globularity in five separate subsamples

-   These SNPs affect neural expression of two genes linked to neurogenesis and myelination
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